Seller record · Telehealth service

Freeley

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S4, compounding disclosure: The program describes compounded semaglutide and licensed compounding partners without a plain not-FDA-approved disclosure on the public weight-loss or process pages. 2 more criteria also fail; see the table below.

At a glance

FreeleyTelehealth service

5/8criteria passed

Price: Printed on its own pages before sign-up
Sells: compounded semaglutide, compounded tirzepatide
FDA letters: None on file

Visit Freeley See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth platform offering physician-reviewed compounded GLP-1 treatment with full-term prepayment and different monthly equivalents depending on the plan length.

Operating entity Freeley Health LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Freeley's how it works page
S2	Prescription gating	PASS	Freeley's how it works page
S3	Pharmacy identification	PASS	Freeley's weight loss page; Freeley's terms
S4	Compounding disclosure	FAIL	Freeley's weight loss page; Freeley's how it works page
S5	Analytical documentation	FAIL	Freeley's weight loss page; Freeley's how it works page
S6	Business address	FAIL	Freeley's contact page; Freeley's about page; Freeley's terms
S7	Price disclosure	PASS	Freeley's weight loss page; Freeley's compare page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA board-certified physician licensed in the patient’s state reviews the intake, evaluates eligibility and writes the treatment plan.Source: Freeley's how it works page.

S2PASSThe public sequence places medical intake and physician review before the patient receives the treatment plan and medication is compounded.Source: Freeley's how it works page.

S3PASSThe weight-loss page identifies Strive Pharmacy as its compounding partner. The terms also name The Pharmacy HUB LLC in Miami Gardens and Triad Rx in Daphne.Source: Freeley's weight loss page; Freeley's terms.

S4FAILThe program describes compounded semaglutide and licensed compounding partners without a plain not-FDA-approved disclosure on the public weight-loss or process pages.Source: Freeley's weight loss page; Freeley's how it works page.

S5FAILThe site claims potency, sterility and purity testing but does not publish a certificate of analysis or equivalent lot document on the program or process pages.Source: Freeley's weight loss page; Freeley's how it works page.

S6FAILThe company, contact and terms pages do not establish a street address for Freeley itself. The addresses in the pharmacy list belong to the dispensing partners.Source: Freeley's contact page; Freeley's about page; Freeley's terms.

S7PASSThe weight-loss page lists compounded semaglutide at $299 for one month, $259 a month for three months, $229 for six months, $199 for twelve months and $179 for twenty-four months, billed for the full selected term. Its separate comparison page instead says $99 a month on a twelve-month plan, an unresolved internal price conflict.Source: Freeley's weight loss page; Freeley's compare page.

S8PASSNo FDA warning letter names Freeley or Freeley Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Freeley

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.